Correction to: Nature Communications https://doi.org/10.1038/s41467-019-09614-y, published online 09 April 2019.
The original version of this Article omitted the following from the last sentence of the Acknowledgements:
This work was supported through an NIH Bench-to-Bedside award made possible by the Office of Rare Diseases Research and NIH Bench-to-Bedside Program funds. This has now been corrected in both the PDF and HTML versions of the Article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Pavel-Dinu, M., Wiebking, V., Dejene, B.T. et al. Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells. Nat Commun 10, 5624 (2019). https://doi.org/10.1038/s41467-019-13620-5
Published:
DOI: https://doi.org/10.1038/s41467-019-13620-5
This article is cited by
-
CRISPR-Cas9 engineering of the RAG2 locus via complete coding sequence replacement for therapeutic applications
Nature Communications (2023)
-
Gene therapy using haematopoietic stem and progenitor cells
Nature Reviews Genetics (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
